TORONTO, Ontario, August 15, 2022 – Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”) today released its financial results for the three and six months ended June 30, 2022. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.

Q2 2022 Highlights and Subsequent Events

 —  Total net revenues from sale of adult use cannabis in Canada of $27.3 million for the three months ended June 30, 2022, a 31% increase from the same period last year;

 —  SG&A remained relatively flat quarter‐over‐quarter as the Company continues to focus its efforts on reducing costs;

—  Adjusted EBITDA improved to negative $4.0 million, an improvement of 37% as compared to the previous quarter;

 —  Auxly Leamington continues to contribute to positive gross margins through low‐cost cultivation and increased yields;

 —  Continued to hold the #1 LP position in Cannabis 2.0 sales nationally as the Company continues to launch new and exciting cannabis products to the Canadian market;

 —  Successfully launched 27 new SKUs to the Canadian market in the first half of 2022 including five first to‐ market products such as Dosecann’s CBN capsules and two new unique dried flower strains, Sticky Monkey and Tranquil Elephantizer under Kolab Project;

  —  Further strengthened the Company’s balance sheet with the sale of both Nova Scotia cultivation assets for total proceeds of $10.1 million to date.

Read full release on Newswire here.

Auxly Financials and Filings.

TORONTO, Ontario, August 10, 2022 – Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, announced today that the Company has closed the sale of its Auxly Annapolis OG Inc. outdoor cultivation facility located in Hortonville, Nova Scotia to a private purchaser for total proceeds to the Company of $4.1 million. As previously announced by the Company, Auxly closed both its cultivation facilities located in Nova Scotia in February 2022 and sold its Auxly Annapolis indoor cultivation facility in July 2022 for total proceeds to the Company of $6 million. The Company intends to apply the proceeds from both sales to support Auxly’s ongoing operations.

“The sale of the Auxly Annapolis outdoor facility for $4.1 million further strengthens the Company’s cash position as we have now received a cumulative $10.1 million for both our Nova Scotia cultivation assets,” said Hugo Alves, CEO.  “We remain committed to identifying opportunities to reduce costs, streamline operations and source additional capital in a non-dilutive way as we continue to focus our efforts of achieving our goal of becoming Adjusted EBITDA profitable in 2022.”    

ON BEHALF OF THE BOARD

“Hugo Alves”CEO

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the proposed use of the proceeds of the sale; the Company’s execution of its product development, commercialization strategy and expansion plans; the relevance of the Company’s current and proposed products; the expectation and timing of future revenues; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company’s subsidiaries are able to maintain the necessary regulatory authorizations to conduct business; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2021 dated March 30, 2022.

The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Aug. 8, 2022 /CNW/ – Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its second quarter 2022 ended June 30, 2022, on Monday August 15, 2022, before the financial markets open.

The Company will host a conference call to discuss the results.  The teleconference details are listed below:

Date: Monday August 15, 2022

Time: 10:00 a.m. EST.  Please dial in at least 10 minutes prior to the start time.

North American Toll Free: 1-888-664-6383

Audio Webcast URL:
https://app.webinar.net/ZxQ6J3oJ7nd

A replay of the teleconference will be available within 24 hours after the conclusion of the call on the Company’s website.

ON BEHALF OF THE BOARD

“Hugo Alves” CEOAbout Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

SOURCE Auxly Cannabis Group Inc.

For further information: Investor Relations: For investor enquiries please contact our Investor Relations Team: Email: IR@35.183.62.152, Phone: 1.833.695.2414; Media Enquiries (only): For media enquiries or to set up an interview please contact: Email: press@35.183.62.152

TORONTO, Aug. 2, 2022 /CNW/ – Auxly Cannabis Group Inc. (TSX: XLY) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, is thrilled to introduce a new extension to its Foray brand: Edi’s. While keeping true to Foray’s pedigree of approachability and accessibility, Edi’s is bringing the fun back into snacking with a bold and honest attitude that will speak to consumers looking to enjoy an edible snack while controlling their cannabis experience.

Launching this new brand extension into the market is Edi’s Gumdrops, a delightfully chewy, premium gummy that is bursting with familiar flavours of lemon, lime, cherry and orange. With 20 snackable pieces per pack, these low-dosed edibles offer 0.5mg of THC per bite – the first of its kind in Canada – allows consumers to enjoy the snacks they love without concern of overindulging in potent THC cannabis products. 

“As we look to continue our expansion into the growing edibles category, we’ve listened to our consumers and their requests for a more approachable and flexible dosing format,” said Michael Lickver, President of Auxly.  “Canadian consumers have been restricted to enjoying only one or two pieces of gummy or chocolate when purchasing their edibles, leaving much to be desired.  Fitting effortlessly into our Foray brand’s targeted consumer base, Edi’s will enable consumers to enjoy these new perfectly low-dosed edible products for a more gratifying snack-like experience.  We believe Edi’s is the disruptive new edible product that the Canadian cannabis consumer has been waiting and asking for and we can’t wait to show our consumers we’ve been listening.”     

Edi’s Gumdrops will be available for Canadian consumers to enjoy by the end of August, with two additional familiar Foray consumer favourites, CBD Blood Orange and CBN Blackberry Lavender, joining the Edi’s family later this summer.

ON BEHALF OF THE BOARD

“Hugo Alves” CEOAbout Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the Company’s execution of its product development and commercialization strategy; the successful production and launch of future Edi’s products; the relevance of the Company’s current and proposed products; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, July 5, 2022 /CNW/ – Auxly Cannabis Group Inc. (TSX: XLY) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that the Company has closed the sale of its Auxly Annapolis Inc. indoor cultivation facility located in Kentville, Nova Scotia to a private purchaser for total proceeds to the Company of $6 million. As previously announced by the Company, Auxly ceased operations at the cultivation facility in February 2022. The Company intends to apply the proceeds from the sale to support Auxly’s ongoing operations.

“We are pleased with the sale of our Annapolis indoor facility,” said Hugo Alves, CEO.  “Being able to monetize this non-core asset to strengthen our cash position in a non-dilutive way is fantastic for the company and provides us with additional capital to support Auxly’s strategic objectives.”

ON BEHALF OF THE BOARD

“Hugo Alves” CEOAbout Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the proposed use of any proceeds of the sale; the Company’s execution of its product development, commercialization strategy and expansion plans; the relevance of the Company’s current and proposed products; the expectation and timing of future revenues; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company’s subsidiaries are able to maintain the necessary regulatory authorizations to conduct business; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2021 dated March 30, 2022.

The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, June 30, 2022 – Auxly Cannabis Group Inc. (TSX- XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) announced today the voting results from its annual general meeting of shareholders held on June 30, 2022 (the “Meeting”).

A total of 159,835,106 common shares of the Company, representing 17.85% of the issued and outstanding common shares of the Company, were voted in connection with the Meeting by shareholders and proxy holders.

All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s information circular dated May 20, 2022 (the “Circular”), were approved by the requisite majority of the votes cast at the Meeting. The results are set out below.

Each of the directors listed as a nominee in the Circular was elected as a director of the Company at the Meeting. The detailed results of the vote for the election of directors held at the Meeting are set out below:

At the Meeting, Auxly shareholders approved the re-appointment of Ernst & Young LLP (“EY”) as the Company’s auditors for the 2022 fiscal year and authorized the board of directors to fix its remuneration. 

A report of voting results on all resolutions voted on at the Meeting will be available on SEDAR at www.sedar.com.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, June 23, 2022 – Auxly Cannabis Group Inc. (TSX: XLY) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that it has amended and restated the unsecured convertible debentures in the capital of the Company (“Original Convertible Debentures“) issued under its standby facility (the “Standby Facility“) with an institutional investor (the “Investor“), which was previously announced on April 28, 2020.

The Standby Facility allowed the Corporation to sell, on a private placement basis, Original Convertible Debentures in tranches for an aggregate principal amount of up to $25 million. Under the Standby Facility, the Company sold $11.25 million in Original Convertible Debentures over five tranches throughout 2020. As of the date hereof, the Company has repaid $2.5 million of principal owing under such Original Convertible Debentures.

The Investor and the Company have agreed to amend and restate the remaining Original Convertible Debentures (the “2022 Convertible Debentures“) on the following terms:

• — $8.75 million aggregate principal amount will remain outstanding until July 15, 2022, where on such date the Company will repay $1.25 million thereby reducing the aggregate principal amount to $7.5 million;
• — extended maturity date for the balance of the $7.5 million principal amount until August 15, 2024 (the “Maturity Date“);
• — guaranteed interest rate of 7.5% per annum, payable semi-annually;
• — reduced conversion price of $0.1380 being convertible at the option of the holder into common shares in the capital of the Company (“Common Shares“) at any time prior to the Maturity Date;
• — removal of the Company’s previous conversion rights; and
• — inclusion of certain repayment conditions should the Company raise additional capital prior to the Maturity Date.

As consideration for amending 2022 Convertible Debentures, the Company has paid the Investor an amendment fee of $500,000 through the issuance of 4,347,826 Common Shares and issued the Investor warrants to purchase 20,000,000 Common Shares, with each warrant being exercisable for a period of 36 months following the date of issuance at a price per share of $0.1495. All securities issued by the Company as consideration for the amendment are subject to a statutory four-month hold period in accordance with applicable securities legislation.  The TSX has provided its notice of conditional acceptance to the proposed amendments and the issuance of the securities to the Investor, subject to the Company filing the necessary documents in the ordinary course pursuant to the notice.

Under the Standby Facility, the Company issued the Investor an aggregate of 20,031,747 Common Share purchase warrants (“Warrants“) throughout 2020, of which 8,510,800 Warrants have expired unexercised; 5,409,836 Warrants with an exercise price of $0.366 will expire on June 26, 2022; and 6,111,111 Warrants with an exercise price of $0.216 will expire on September 8, 2022.

In connection with the amendment of the 2022 Convertible Debentures, the Company has agreed to indemnify (the “Indemnity“) certain of its directors and officers for any and all losses not otherwise recoverable from the collateral provided by the Investor for the Common Shares provided by such directors and officers to the Investor pursuant to the terms of the transaction. The Indemnity may constitute a related party transaction under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“), but is otherwise exempt from the formal valuation and minority approval requirements of MI 61-101. The Indemnity has been approved by the independent directors of the Company. No special committee was established in connection with the amendment of the 2022 Convertible Debentures or the granting of the Indemnity, and no materially contrary view or abstention was expressed or made by any director of the Company in relation thereto.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any of the securities referenced herein in the United States. The securities referenced herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is availableAbout Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:     
Email: press@35.183.62.152 Notice Regarding Forward Looking Information:  

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the timing of any future payments under the 2022 Convertible Debentures; political change; future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company can complete any further payments under the 2022 Convertible Debentures on the anticipated terms and timeline; ; and general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company and its subsidiaries and partners operate will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2021 dated March 30, 2022.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and the reader is cautioned that such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, June 6, 2022 – Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) announced today that it will hold its Annual General Meeting of Shareholders (the “Meeting”) on Thursday, June 30, 2022 at 10:00 a.m. EST at the offices of McCarthy Tétrault LLP, Suite 5300, TD Bank Tower, Toronto, Ontario M5K 1E6. 

The venue has limited seating, as such, shareholders who wish to attend in person will be required to pre-register with the Company by emailing IR@35.183.62.152 at least 48 hours in advance of the Meeting.  Early registration is encouraged.  In addition, certain COVID 19 protocols remain in force, whereby proof of vaccination will be required at the venue, and any shareholder who does not provide notice and receive approval from the Company to attend will not be admitted to the Meeting.

To allow shareholders to follow the conduct of the Meeting, the Company is providing an audio teleconference that can be used by participants to listen to the Meeting in real time.

Teleconference Details

Date: Thursday June 30, 2022

Time: 10:00 a.m. EST.  Please dial in at least 10 minutes prior to the start time.

North American Toll Free:  1-888-664-6383

Audio Webcast URL:

https://produceredition.webcasts.com/starthere.jsp?ei=1550036&tp_key=2d74d99faa

Please note that shareholders will not be entitled to vote at, or otherwise participate in, the Meeting by way of teleconference or other electronic means, and so we encourage shareholders to vote in advance of the Meeting in accordance with the instructions provided in the materials for the Meeting, including the Management Information Circular, which is available on SEDAR as well as the Company’s website.  

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, June 2, 2022 – Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is thrilled to announce that the Company was named Licensed Producer of the Year at last night’s O’Cannabiz Industry Awards Gala.  This award recognizes top service, top quality products and LPs that make a true contribution to the future as voted by the cannabis industry itself.

“We are proud and honoured to be named Licensed Producer of the Year,” said Hugo Alves, CEO of Auxly.  “This award validates the hard work of an incredible team that has remained dedicated to our customers and our consumers. I want to thank everyone at Auxly, our customers, retail partners and our incredible consumers for all of their efforts and support.  This is really your award!  I’d also like to congratulate all of the other nominees; we at Auxly are humbled to be considered alongside this group of industry leaders.”     

Along with Licensed Producer of the Year, Auxly received several additional nominations for its industry-leading brands and innovative product suite, including:

•  — Brand of the Year for its award winning Back Forty brand;
•  — Favourite Vaporizer with Foray’s Mango Haze All-in-one Vape;
•  — Favourite CBD & Topicals with Dosecann’s award winning Daily CBD Relief Cream;
•  — Favourite Product of the Year with Kolab Project’s Live Terpene Sticks;
•  — Favourite Edible Product with Kolab Project’s Cherry Cola Pop Milk Chocolate Square; and
•  — Favourite Capsules, Extracts, Concentrates with Kolab Project’s THCA Diamonds.

Auxly is driven by a mission to help consumers live happier lives by consistently delivering new and exciting high-quality cannabis products under brands that consumers can trust and love.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian consumer packaged goods company in the cannabis products market, headquartered in Toronto, Canada. The Company’s focus is on developing, manufacturing and distributing branded cannabis products that delight wellness and recreational consumers and deliver on its consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

 TORONTO, Ontario, May 16, 2022 – Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three months ended March 31, 2022. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. 

Q1 2022 Highlights

 —  147% increase in net sales compared to Q1 in 2021 – recorded net revenues of $22.6M for the three months ended March 31, 2022; 

 —  SG&A of $12.8M in Q1 2022 decreased slightly quarter-over-quarter with the full quarter consolidation of Auxly Leamington; 

 —  Adjusted EBITDA improved year-over-year by approximately 14%; 

 —  Continue to hold the #1 LP position in Cannabis 2.0 sales nationally; 

 —  Back Forty remains the #1 vape brand in the country and became the #4 flower brand nationally in the quarter; 

 —  Maintained its position as one of the top 5 LPs in Canada in total cannabis sales with 6.9% market share; 

 —  With growing competition in vapes, the largest 2.0 product category, Auxly continued to hold the #1 LP position in national sales with 20% market share; 

 —  Successfully launched 10 new SKUs into the market in the quarter, including solventless live rosin vapes, new infused pre-roll strains and the first-to-market Live Rosin Chew all under Kolab Project brand; 

 —  Recorded non-cash impairment of approximately $25.7M related to the closure of Auxly Annapolis and Auxly Annapolis OG cultivation facilities. 

Read full release on GlobeNewswire here.

Auxly Financials and Filings.

TORONTO, May 10, 2022 /CNW/ – Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its first quarter 2022 ended March 31, 2022, on Monday May 16, 2022, before the financial markets open.

The Company will host a conference call to discuss the results. The teleconference details are listed below:

Date: Monday May 16, 2022

Time: 10:00 a.m. EST.  Please dial in at least 10 minutes prior to the start time.

North American Toll Free: 1-888-664-6383

Audio Webcast URL:
https://produceredition.webcasts.com/starthere.jsp?ei=1547591&tp_key=a22d69f22f

A replay of the teleconference will be available within 24 hours after the conclusion of the call on the Company’s website.

ON BEHALF OF THE BOARD

“Hugo Alves” CEOAbout Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market. 

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

SOURCE Auxly Cannabis Group Inc.

For further information: Investor Relations: For investor enquiries please contact our Investor Relations Team: Email: IR@35.183.62.152, Phone: 1.833.695.2414; Media Enquiries (only): For media enquiries or to set up an interview please contact: Email: press@35.183.62.152

TORONTO, Ontario, March 31, 2022 – Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, today released its fourth quarter and full year 2021 financial results. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.

2021 Highlights

 —  Recorded net revenues of $83.8 million in 2021, an increase of 79% compared to 2020;

 —  Fourth quarter net Cannabis revenues of $29.3 million, a 20% increase QoQ;

 —  Maintained the #1 LP position in Canada for Cannabis 2.0 product sales1 in 2021, increasing its market share to approximately 15% (up from 14% in 2020);

 —  Continued to dominate national vapour sales with its award‐winning portfolio, achieving 23% market share for the year (up from 19% in 2020), and securing the #1 LP position;

 —  Exiting 2021 as the 5th largest LP in Canada by share of market based on total dollar sales, securing 7.4% in the fourth quarter;

 —  Successfully expanded its branded product offering into dried flower and pre‐roll categories with the launch of new and exciting product formats that include the award‐winning Back Forty 40s, as its dried flower portfolio led the growth in the category at OCS, growing 189% and securing the #7 LP position in national sales in Q4;

 —  Enhanced the Company’s cultivation capabilities and vertical integration with the acquisition of its joint venture project, Auxly Leamington Inc. (formerly Sunens);

 —  Strengthened its Board of Directors with the appointment of Murray McGowan, strategic partner Imperial Brands’ Chief Strategy and Development Officer;

 —  Strengthened the Company’s financial position with the sale of two non‐core assets and extension of Imperial Brands $123 Million convertible debenture;

 —  SG&A remained relatively flat year‐over‐year while the Company continued to enhance and expand its product portfolio, increasing sales by almost 80%;

 —  Successfully grew national brand awareness across all four in‐house proprietary brands as the Company continued to build deeper connections with its targeted consumers, delivering differentiated and innovative products that meet their growing needs and demands.

Read full release on GlobeNewswire here.

Auxly Financials and Filings.

Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its fourth quarter and full year ended December 31, 2021, on Thursday March 31, 2022, before the financial markets open.

The Company will host a conference call to discuss the results. The teleconference details are listed below:

Date: Thursday March 31, 2022

Time: 10:00 a.m. EST. Please dial in at least 10 minutes prior to the start time.

North American Toll Free: 1-888-664-6383

Audio Webcast URL:
https://produceredition.webcasts.com/starthere.jsp?ei=1535919&tp_key=5f2b492569

A replay of the teleconference will be available within 24 hours after the conclusion of the call on the Company’s website.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only):

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152

Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, announced today that the Company has closed its Robinsons cultivation facilities located in Kentville and Hortonville, Nova Scotia, as the Company continues to focus its efforts on streamlining and simplifying its cultivation platform, reducing costs and achieving its goal of becoming adjusted EBITDA positive by the first half of this year.

This strategic decision comes after careful consideration in identifying opportunities for the Company to optimize its vertically integrated platform and effectively reduce operating costs, while ensuring no material impact on its cultivation or processing capabilities and forecasted sales revenue. Through streamlining its cultivation footprint, the Company will be able to focus efforts and resources on optimizing the output of high-quality cannabis from its newly acquired large-scale greenhouse cultivation facility located in Leamington, Ontario. Auxly Leamington, formerly called Sunens Farms Inc., is a 1.1 million sq. ft. facility producing unique cannabis strains that are currently being used in the Company’s full suite of industry-leading branded cannabis products. Auxly Leamington also provides the Company with considerable additional cultivation, storage, processing and manufacturing space, affording Auxly the ability to scale its operations in concert with the increasing demand for its portfolio of quality branded products and gain further economies of scale.

Robinsons Cannabis Incorporated, located in Kentville, Nova Scotia, operated a 27,700 sq. ft. indoor cultivation facility that focused on the production of high-quality craft cannabis. Robinsons Outdoor Grow Incorporated (“Robinsons OG”) is an outdoor cannabis cultivation project comprised of over 158 acres of land located in Hortonville, Nova Scotia. The Company never commenced cultivation activities at Robinsons OG, instead utilizing the space for additional storage and processing capacity. The Company intends to divest these non-core assets and apply the proceeds from any such sale to support Auxly’s ongoing operations.

“While we believe that taking these steps ultimately makes Auxly a more focused company that is better positioned to achieve its strategic goals, it was an extremely difficult decision because of the impact on our talented and hard-working Robinsons employees. We are grateful for all of their efforts and will do our best to help support them through this period of transition,” said Hugo Alves, CEO of Auxly. “We are diligently working to ensure that we achieve our goal of reaching adjusted EBITDA positive by the first half of 2022 and deliver stable and profitable financial performance for our stakeholders. Optimizing our vertically integrated platform allows us to strengthen our capital position, increase the overall efficiency of our operations and enhance our ability to continue to meet the growing demand for Auxly branded products.”

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the proposed operation of the Company and its subsidiaries; the Company’s efforts to streamline its cultivation operations and reduce operating costs; the intention of the Company to sell the non-core assets and the proposed use of any proceeds; the Company’s execution of its product development, commercialization strategy and expansion plans; the relevance of the Company’s current and proposed products; the expectation and timing of future revenues; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company is able to execute on its business strategy; the Company is able to sell the non-core assets; the Company is able to achieve the anticipated cost savings from the closure of the facilities; the Company’s subsidiaries are able to maintain the necessary regulatory authorizations to conduct business; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2020 dated April 23, 2021.

The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Jan. 13, 2022 — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is thrilled to report its continued national leadership in Cannabis 2.0 product sales in 2021, securing a 15% share of the growing category (up from 14% in 2020), as confirmed by Headset Canadian Insights data. The Company’s #1 spot is driven by its dominance in the vapour segment, where it achieved 23% national market share for the year, with all three of its vape brands – Back Forty, Kolab Project and Foray – securing a spot in the top 5 selling brands across the country.

The Company also saw a steady quarter-over-quarter growth in total market share, achieving its strategic objective of reaching the #5 LP position in overall sales by the end of 2021. As one of the few Canadian LPs to gain market share throughout the year, Auxly successfully captured 7.4% of the total market in Q4 2021 (up from 4% in Q1 2021), securing a new leading position among the top performing LPs in the country. Leading the growth in market share was the Company’s expansion into dried flower and pre-rolls, which still account for over 75% of national cannabis sales, and remains a key growth driver for Auxly going into the new year where it will leverage the added support of its newly acquired 1.1 million sq. ft. greenhouse cannabis cultivation facility in Leamington, ON.

“2021 was a phenomenal year for Auxly. It validated our focused strategy of bringing innovative and differentiated products to the Canadian cannabis market under brands that consumers can trust and love,” said Hugo Alves, CEO of Auxly. “I want to express my utmost gratitude to everyone at Auxly for their hard work and determination, especially during another year of the pandemic. We’ve solidified our position within the top-ranking LPs in the country and have no intention of slowing down as we further optimize our operations to facilitate long-term growth and continue to build deeper connections with our targeted consumers through our innovative branded cannabis products. We couldn’t be more excited for 2022.”

Additional Operational Highlights for 2021 Include:

• —Launched 52 SKUs in 2021, including 10 first-to-market innovations such as Kolab Project 232 Series Live Terpene Sticks;
• —Made significant progress in building to leadership in both the dried flower and pre-roll categories with the launch of new and exciting product formats that include Back Forty 40s and the introduction of unique cannabis strains that Canadian consumers trust and love, like one of Ontario’s top selling dried flower SKUs, Back Forty’s Wedding Pieⁱⁱ;
• —Acquired the remaining equity interest in its joint venture project, Sunens Farm Inc., a state-of-the-art, 1.1 million sq. ft. greenhouse cannabis cultivation facility in Leamington, Ontario, providing the Company with complete control over large-scale cultivation and access to a proprietary genetic library of more than 150 cannabis strains to supply its growing product suite;
• —Strengthened its Board of Directors with the appointment of Murray McGowan, strategic partner Imperial Brands’ Chief Strategy and Development Officer; and
• —Graduated to the Toronto Stock Exchange, raising the Company’s profile in the investment community as it strives to build long-term shareholder value.

As the Company looks ahead to 2022, Auxly continues to be driven by its unwavering commitment to Canadian consumers, helping them live happier lives through its curated portfolio of branded cannabis products that deliver on the Company’s promise of quality, safety and efficacy.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the Company’s execution of its product development, commercialization strategy and expansion plans; the relevance of the Company’s current and proposed products; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company is able to maintain and grow its market share; the Company’s subsidiaries and partners are able to maintain the necessary regulatory authorizations to conduct business; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2020 dated April 23, 2021.

The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

• — Canada-wide panel of nearly 250 budtenders recognizes Auxly brands with four wins at the second annual Kind Awards
• — Auxly dominates the vape cartridge category, with wins for “Best Sativa Cartridge” and “Best Indica Cartridge”
• — After fewer than four months on the market, Back Forty 40s win “Best Indica Pre-Roll”
• — Dosecann Daily Relief CBD Cream wins inaugural “Best Topical” category

TORONTO, Dec. 16, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is thrilled to announce that the Company received four awards for its popular consumer brands Back Forty, Kolab Project and Dosecann at the second annual Kind Awards – tied for the most of any Licensed Producer. These awards are published in Kind Magazine and recognize the very best in Canadian cannabis, as determined by a panel of nearly 250 budtenders across Canada.

“Budtenders are the most important influencers in the industry, guiding consumer purchasing decisions every day in retail outlets across the country,” said Andrew MacMillan, Senior Vice President of Commercial at Auxly. “We are thrilled to have them recognize the quality and value of our pre-rolls, vapes and topical cream in this year’s Kind Awards. On behalf of everyone at Auxly – thank you to Canada’s budtenders for validating our efforts with your recognition and for helping consumers find their way in Canadian cannabis. And thank you to Kind Magazine for providing an invaluable in-store resource with compelling educational and entertaining content.”     

Back Forty received top honours in both “Best Indica Pre-Roll” and “Best Indica Cartridge” categories. These awards cap a historic 2021 for the brand, as it currently holds the #1 vape brand position in the country and is the fastest-growing brand overall in Canada’s largest market, Ontarioⁱ. The Kind Award-winning Forbidden Fruit cartridge was recently launched in a new 1.2g format in B.C. and Alberta, alongside Back Forty’s other consumer-favourite strains Kush Mint, Sour Apple and Super Lemon Haze. Back Forty introduced its 40s pre-rolls in late August with the potent Wedding Pie and Animal Mints cultivars; these pre-rolls have quickly become a must-have for consumers and have propelled Back Forty to the #5 brand position in its launch market of Ontarioⁱⁱ after less than four months of commercial sales.

Kolab Project was awarded the “Best Sativa Cartridge” for its 157 Series Strawberry Ice Sativa cartridge, giving Auxly two out of three awards in the vape category. Strawberry Ice Sativa is a highly potent vape and is Kolab Project’s take on the unique Strawberry Ice strain with Myrcene as the dominant terpene. Strawberry Ice Sativa offers premium hardware, hard-hitting potency and outstanding taste, all in recyclable packaging.

Rounding out Auxly’s Kind Awards wins is Dosecann, recognized for its innovative Daily Relief CBD Cream, which garnered the inaugural win for the magazine’s new “Best Topical” category. Dosecann Daily Relief CBD Cream has 1,200 mg of CBD per 60 ml unit – an industry-leading potency that is competitively priced to deliver the best value for a CBD topical. Dosecann Daily Relief CBD Cream combines high-quality CBD extract with Natralipid® Meadowfoam seed oil, a plant-based emollient found in high-end skin creams and valued for moisturization, transdermal barrier repair, skin penetration and unsurpassed stability.

These distinctions validate the Company’s quality-driven approach to delivering unique cannabis product innovations to Canadian consumers. As the New Year quickly approaches, Auxly will continue to invest in delivering differentiated cannabis products under its award-winning brand portfolio with its sights set on becoming the #1 LP in the country.

ON BEHALF OF THE BOARD        

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.         

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:        
Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:        

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: Auxly’s execution of its product development and commercialization strategy; the ability of the Company to maintain and grow its market share; consumer preferences, political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for Auxly’s current and future products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

ⁱ Headset Canadian Insights, Back Forty is ranked #3 brand overall in Ontario as of November 30, 2021
ⁱⁱ Headset Canadian Insights, as of November 30, 2021.

• —Auxly acquires remaining equity interest and secures 100% ownership of Sunens Farms Inc.
• —Currently utilizing output from Sunens in its 1.0 and 2.0 cannabis products, including Ontario’s current top-selling dried-flower SKU, Back Forty’s Wedding Pieⁱ
• —Provides immediate improvement to gross margins and reduces reliance on large-scale wholesale cannabis purchases
• —Amends and restates its credit facility with BMO, extending the initial maturity date by a year to September 2023, and pays down existing credit facility by $15M 

TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, today announced that it has acquired 100% ownership of Sunens Farms Inc. (“Sunens”). Pursuant to a share purchase agreement between Auxly and Peter Quiring, the Company acquired all the issued and outstanding securities of Sunens not already owned by Auxly (the “Acquisition”). Concurrent with the Acquisition, Sunens and the Company have amended and restated Sunens’ secured credit facility that was entered into in September 2019 (as amended, the “Amended and Restated Credit Facility”) underwritten by a syndicate of lenders led by the Bank of Montreal (“BMO”), bringing the total principal indebtedness thereunder to $62.5 million.

Transaction Details

Auxly acquired all of the issued and outstanding securities of Sunens not already owned by Auxly from Peter Quiring for consideration of: (i) $1.6 million, comprised of $500,000 in cash and $1.1 million in Auxly common shares; (ii) a $3.4 million unsecured promissory note payable over 30 months in equal monthly installments with the first payment due 12 months after the date of closing; and (iii) the transfer of certain non-core assets of Sunens.

Concurrent with the Acquisition, Sunens has entered into an Amended and Restated Credit Facility with the following terms:

• —An immediate cash payment by Auxly of $15 million applied to the outstanding principal balance of the revolving credit facility, bringing the outstanding principal amount thereunder to $62.5 million;
• —Extension of the maturity date by a year to September 30, 2023, with an option for Sunens to extend for an additional year by making a further principal repayment of $5 million by December 31, 2022; and
• —The obligations of Sunens under the Amended and Restated Credit Facility continue to be supported by an unsecured $33 million limited recourse guarantee by Auxly, and a pledge by the Company of all of its securities of Sunens with new revenue and EBITDA covenants.
  

Transaction Rationale

“The acquisition of Sunens, a highly automated greenhouse with a demonstrated ability to grow high-quality cannabis at scale, increases Auxly’s cultivation capabilities and strengthens our position as a leader in the Canadian cannabis market,” said Hugo Alves, CEO of Auxly. “Having full ownership and operational control of Sunens gives us the security of supply, quality control, economies of scale and genetic exclusivity that will enable us to continue delivering quality products to our consumers under brands that they can trust. The ability to fully consolidate the activities of Sunens will improve gross margins and support Auxly’s path to profitability.”

• —The Company will immediately begin integrating Sunens’ proven cultivation capabilities, giving Auxly the competitive advantages of scale, lower costs and surety of supply as it continues to build to leadership in 1.0 cannabis product formats following on the success of its Back Forty branded flower and pre-rolls product launches.
  
          
• —The Acquisition will result in improvements in Auxly’s blended gross margins, adjusted EBITDA and net income as Sunens continues to increase production while eliminating the reliance on Auxly’s third-party cannabis purchases.
  

• —The facility is fully licensed for cultivation, processing and sales under the Cannabis Act and provides the Company with operational flexibility as well as considerable additional cultivation, storage, processing and manufacturing capacity and the ability to continue scaling cultivation to meet the growing consumer demand for Auxly’s branded products.
  

“This is a defining moment for Auxly. Our commitment to quality and consistency in every product we put out in the market has continued to gain consumer trust and brand loyalty,” said Mike Lickver, President of Auxly. “Sunens helps us deepen the connection with our consumers by ensuring we are meeting their needs through thoughtful innovation and product format development. We are thrilled to officially welcome the outstanding people at Sunens to our organization, and it couldn’t come at a better time. We are working hard to meet the fast-growing consumer demand for our entire suite of products and having a library of unique genetics and a consistent supply of high-quality cannabis will help us ensure that all of our products get to and stay on shelves across the country.”

• —The transaction provides the Company with complete control over large-scale cultivation with a proprietary genetic library consisting of more than 150 cannabis strains, empowering Auxly to tailor its products to evolving consumer preferences and support the Company’s growing portfolio in both the 1.0 and 2.0 cannabis product categories.
  
• —Sunens is already producing unique cannabis strains, including Ontario’s top-selling Wedding Pie, as well as Animal Mints and Fruity Pebbles OG – all of which are currently sold to and used exclusively by Auxly for its full suite of cannabis products.
  

Auxly remains focused on bringing new, innovative branded cannabis products to Canadian consumers and believe that this Acquisition will allow for continued growth, improved cost structure and near-term positive adjusted EBITDA.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the anticipated benefits of the Company’s acquisition of Sunens; the Company’s execution of its product development and commercialization strategy; the intention to grow the business, operations and existing and potential activities of Auxly and Sunens; the expectation and timing of future revenues; the ability of the Company to maintain and grow its market share; discussions of plans or potential for expansion of capacity at the Sunens facility; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: Sunens performs consistently with management’s expectations; Sunens will generate sufficient cash flow to satisfy its payment obligations under the Amended and Restated Credit Facility; Sunens will remain in compliance with its operating covenants under the Amended and Restated Credit Facility; the Company is able to successfully integrate Sunens’ operations with its own; the expected benefits of the acquisition materialize in the manner expected, or at all; Sunens is able to maintain the necessary governmental and regulatory authorizations to conduct business; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company and its subsidiaries operate will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2020 dated April 23, 2021.

The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Nov. 15, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, today released its financial results for the three and nine months ended September 30, 2021. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.

Q3 2021 Highlights and Subsequent Events

• — Total net revenues of $24.5 million for the three months ended September 30, 2021 improved by approximately 95% year over year and 17% sequentially.
• — Adjusted EBITDA of negative $6.5 million, improved modestly over the same period in 2020, however, increased over the previous quarter Continued growth in national recreational cannabis sales, maintaining the #1 LP position in Cannabis 2.0 sales with 15.6% market share and securing the #6 LP position in total national recreational cannabis sales in the quarter, with continued growth in the month of October moving the Company into the #5 LP position with 7.3% share of market¹.
• — Continued leadership in new product innovation with the launch of new and differentiated SKUs throughout the quarter, including the introduction of Back Forty 40s, and Kolab Project 132 Series Live Resin Black Cherry Punch Soft Chews, Canada’s first cannabis-infused live resin edible.
• — Strengthened its Board of Directors with the appointment of Murray McGowan, Chief Strategy and Development Officer for Imperial Brands.

Read full release on GlobeNewswire here.

Auxly Financials and Filings.

TORONTO, Nov. 10, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, today introduces a fall lineup packed with innovative new products, flavours and formulations designed to delight Canadian cannabis consumers. This new lineup is launching as the Company announces that it has achieved one of its key 2021 objectives by achieving the #5 position among Canadian Licensed Producers.

Auxly continues to expand its market share in the Canadian cannabis sector through the Company’s strategic growth of its innovative portfolio of branded products. A strong performance for the month of October has helped Auxly achieve one of its key objectives for the 2021 Fiscal Year – to become a Top 5 Canadian Licensed Producer by national market share. October data has vaulted Auxly into the #5 position among Canadian LPs, with a 7.3% share of the national market, as confirmed by Headset Canadian Insightsⁱ. Auxly has continued to gain market share through continued leadership in the cannabis 2.0 segment – where it maintains #1 position in vapesⁱⁱ and the #1 position in the cannabis 2.0 segment overallⁱⁱⁱ – and its successful expansion into the 1.0 segment where strong consumer demand for the Company’s Back Forty and Kolab Project branded products has vaulted the Company into the Top 10 producers for both the dried-flower and pre-roll^iv categories^v.

Looking forward, Auxly today unveils a suite of new product offerings designed to excite and delight Back Forty, Kolab Project and Foray consumers. The product launches this fall include: new seasonal confections that evoke the cozy warmth of the holidays; brand-new innovations; extensions of existing product lines that take Auxly brands in new directions; new dried-flower strains; and new flavours & formulations for Auxly’s industry-leading vape portfolio.

“Every member of our team is delighted by the strong response from consumers to our products,” said Andrew MacMillan, Senior Vice President, Commercial, Auxly. “Our iterative process for innovation is rooted in consumer insights, and driven by the tireless execution of product development, sales and marketing. Seasonal trends are very much a part of our formula and this latest round of product innovations convey the coziness and warmth of fall. We’re thrilled with our continued growth and can’t wait to bring more exciting new products to Canadian cannabis consumers.”

Read full release on GlobeNewswire here.

TORONTO, Ontario, November 2, 2021 – Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that, in connection with its strategic partnership with Imperial Brands PLC (“Imperial”), the Company has appointed Murray McGowan, Chief Strategy and Development Officer for Imperial, to its Board of Directors, effective November 1, 2021. 

Mr. McGowan will join the Auxly Board of Directors as Imperial’s director designee, replacing previous Imperial nominee Conrad Tate.  Mr. Tate has left Imperial but, at the request of the Company, has agreed to remain on Auxly’s Board as an independent director and will also continue to serve on Auxly’s Audit Committee and Compensation Committee.  Mr. McGowan has also been appointed to the Company’s Audit Committee.  Following the appointment of Mr. McGowan, the Board will comprise of six directors.

“We are excited to welcome Murray to our board during an important stage in Auxly’s growth,” said Genevieve Young, Chair of Auxly’s Board of Directors. “Murray’s extensive strategy and development experience will be invaluable to the Company as it continues to grow into one of the leading licensed producers in the country.  We are also thrilled that Conrad has decided to remain on Auxly’s Board after his departure from Imperial as it provides an important piece of continuity.  His experience and expertise has been incredibly valuable over the course of the last two years and we are delighted to be able to retain the benefit of his counsel, insight and support on our Board of Directors.”

Mr. McGowan has a strong background in strategy, having worked in various strategic and operational leadership roles for a number of high-profile businesses including Costa Coffee, Yum! Brands, Cadbury and The Restaurant Group.  He has also worked with a range of leading global consumer goods companies and retail businesses during his time at McKinsey and Company.

“Auxly is quickly becoming a leader in the Canadian cannabis market, and I am delighted to be joining its Board of Directors at such an exciting time,” said Murray McGowan.  “I look forward to contributing to Auxly’s future growth and success.”

ON BEHALF OF THE BOARD

“Hugo Alves”CEO

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

TORONTO, Nov. 01, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its third quarter 2021 ended September 30, 2021, on Monday November 15, 2021, before the financial markets open.

The Company will host a conference call to discuss the results. The teleconference details are listed below:

Date: Monday November 15, 2021

Time: 10:00 a.m. EST. Please dial in at least 10 minutes prior to the start time.

North American Toll Free: 1-888-664-6383

Audio Webcast URL:
https://produceredition.webcasts.com/starthere.jsp?ei=1508777&tp_key=8909709c2d

A replay of the teleconference will be available within 24 hours after the conclusion of the call on the Company’s website.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

TORONTO, Ontario, October 18, 2021 – Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that the Company has moved to the #6 LP position in Canada for total cannabis sales as of the end of Q3 2021 after continuing to win with Canadian consumers and gaining market share through its expanded, high-quality, and innovative portfolio of branded cannabis products.

After the successful launch of new product offerings during the third quarter of 2021, such as the introduction of the Back Forty 40s pre-rolls and differentiated dried flower offerings, Auxly secured 5.7% share of the total cannabis market in Q3 2021, up from 4.9% in Q2 2021, ending the quarter with 6.4% share of market in September.         

“Auxly continues to make strides towards reaching its goal of achieving 7-9% share of market in Canadian recreational cannabis sales by the end of the year through expanded sales growth opportunities founded in consumer insights, innovation and executional excellence,” said Hugo Alves, CEO of Auxly.  “As planned capabilities have come on-line our product line-up has grown to include Cannabis 1.0 products, but our focus remains the same:  to put our consumers first and consistently deliver unique, exciting products under brands that they can trust and love.”

In addition to overall growth and expanded presence in the dried flower segment, Auxly also continues to hold the #1 LP position in Canada for Cannabis 2.0 product sales with 15.6% market share in Q3 2021.  Powered by a 24.7% share of the vapour market – the largest of any Canadian LP by a significant margin – the Company’s organic growth in each of the Cannabis 2.0 categories it participates in is a testament to the quality and efficacy of its product suite that Canadian consumers have come to rely on. 

As the Canadian cannabis market continues to become more competitive, Auxly is outperforming many of its peers in generating sales and share of market growth by remaining focused on executing its targeted expansion into new product categories and building deeper connections with consumers through its popular brands: Kolab Project, Back Forty, Foray and Dosecann.

Read full release on GlobeNewswire here.

TORONTO, Sept. 29, 2021 — Today, Kolab Project announces the launch of 132 Series Live Resin Black Cherry Punch Soft Chews, Canada’s first cannabis-infused live resin edible. Kolab Project 132 Series Live Resin Black Cherry Punch Soft Chews are for cannabis enthusiasts who love the true-to-plant taste of cannabis, and are an extension of Kolab Project’s true-to-strain product line-up that includes the 232 Series Live Terpene vape cartridges and 232 Series Diamonds concentrates. Kolab Project 132 Series Live Resin Black Cherry Punch Soft Chews are available now for purchase on OCS.ca and in retail outlets in Ontario, Alberta, Saskatchewan, and Manitoba, with additional provinces expected to launch in coming months. Kolab Project is a cannabis brand owned and operated by Auxly Cannabis Group (TSXV – XLY) (“Auxly”).

“Kolab Project is committed to presenting high-quality cannabis products that convey the authentic identity of the strain,” said Brad Canario, Senior Director, Marketing, Auxly. “Kolab Project 132 Series Live Resin Soft Chews bring this idea to a new level by offering real flower flavour in an edible format. This Black Cherry Punch formulation is unadulterated – cannabis enthusiasts like the taste of cannabis so we wanted to make sure we launched a product for them without enhancing the flavour profile with any artificial flavor whatsoever.”

Each Kolab Project Live Resin Soft Chew includes high-quality terp sauce extracted from the whole flower of the small-batch, hand-tended Black Cherry Punch strain, which is a cross of Purple Punch and Black Cherry Pie. This terpene- and THCA-rich terp sauce injects the true flavour and aroma of the Black Cherry Punch strain and allows it to shine through with a rich, berry and apple floral flavour due to the strain’s unique terpene profile of limonene, farnesene, beta-caryophyllene, linalool and myrcene. When decarboxylated during the cooking process, the THCA in the terp sauce is converted to THC and provides consumers with an authentic, full-spectrum experience of Black Cherry Punch in an edible format, without added flavour or colour. Kolab Project 132 Series Live Resin Black Cherry Punch Soft Chews are available in packages of two soft chews, each with 5 mg of THC that deliver the potency Kolab Project consumers expect. More single-strain Live Resin Soft Chew flavours will be launched by Kolab Project in coming months.

Kolab Project’s 132 Series takes inspiration from 132 degrees Celsius, the ideal temperature of decarboxylating cannabinoids for edibles. Consumers who appreciate the flavour of the Black Cherry Punch strain may also be interested in Kolab Project’s 232 Series Live Terpene Black Cherry Punch 510 cartridge.

About Kolab Project        
Kolab Project is a cannabis brand, wholly owned by Auxly Cannabis Group Inc., that aims to connect with cannabis enthusiasts who have an appreciation for the positive impact that art, culture and design have on humanity. Kolab Project cannabis products, available at licensed cannabis retailers across Canada, include premium pre-rolls, vapes, concentrates, soft chews and chocolate. Visit us at kolabproject.com.

About Auxly Cannabis Group Inc. (TSX.V: XLY)         
Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly is a team of cannabis enthusiasts, entrepreneurs, CPG professionals, scientists and researchers united in a commitment to our consumers. Auxly creates trusted brands and products in an expanding global market through a tailored cultivation platform, purpose-built facilities and state-of-the-art technologies.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

For more information please contact:
Scott Campbell, 647-402-4957, press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: Auxly’s execution of its product development and commercialization strategy; consumer preferences, political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for Kolab Project products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, August 18, 2021 – Today, Back Forty – a cannabis brand from Auxly Cannabis Group (TSX – XLY) (“Auxly”) – introduces Back Forty 40s, a new, straight-roll offering available now in Ontario at OSC.ca and at cannabis retail stores across the province. 40s are 0.35g single-strain, straight pre-rolls, machine rolled for a consistent, even burn with enhanced airflow and big flavour. Back Forty 40s launch with two high-potency cultivars – Animal Mints and Wedding Pie – and are presented in resealable, recyclable packages of 10, optimized for sharing out of the pack and preserving freshness. Back Forty is introducing 40s with an irreverent marketing campaign using Out-Of-Home advertising to encourage Canadians to unplug and embrace the outdoors by taking Mondays off through the summer. Back Forty 40s are the centrepiece of a summer of new product launches, which also features new dried flower strains and the brand’s first edible offerings.

“We’re thrilled to launch Back Forty 40s for Canada’s savvy cannabis consumers, looking for high-quality products at affordable prices,” said Brad Canario, Senior Director, Marketing, Auxly. “40s are a truly differentiated offering – leveraging state-of-the-art automation to deliver a straight pre-roll in packaging perfect for that last-minute camping trip or long day spent at the lake. For the launch of Back Forty 40s we wanted to make sure we had something unique in the market that delivered on the brand promise of recalling the simple joys found in nature. The Monday Merries is a challenge to all Canadians to focus on what really matters – getting outside – by including Mondays into the mix on the weekends throughout the rest of the summer.”

Back Forty, Canada’s #1 vape brand[i], is launching 40s as the Canadian pre-roll market continues to grow. In 2020, pre-rolls were the second-largest product category in the Canadian market with 17% share of market. So far in 2021, pre-rolls have secured a 19.3% market share through June 30, 2021.[ii]

Back Forty 40s leverage Auxly genetics – the organically grown, high-potency strains Animal Mints and Wedding Pie. Animal Mints is a cross between Animal ​Cookies x SinMint Cookies, reaching potencies of up to 25%, with a total terpene content of up to 2.3%.  Wedding Pie is the marriage of Wedding Cake x Grape Pie, reaching potencies of up to 26%, with up to 2.9% total terpene content.

This high-potency flower is machine rolled into 10 x 0.35g packages using first-of-its kind, state-of-the-art automation designed for consistency, an even burn and optimal air-flow and flavour. Each easy-to-share pack of 40s has a resealable film that locks in the freshness. And in true Back Forty fashion, 40s packaging is 100% recyclable. 40s are available in Ontario now, and will be coming soon to provinces across Canada.

Back Forty is launching 40s with an innovative Monday Merries campaign that flips the script on the negative stigma associated with Mondays. The campaign suggests that the greatest enjoyment is found by turning a Monday into a funday, so instead of going to work, Back Forty invites Canadians to explore their personal back forty, and, in doing so, reclaim the maligned day. The Monday Merries campaign includes social, digital and Out-Of-Home, with wild posting advertising soon to be live in major urban centres across Canada including Toronto, Vancouver, Calgary and Edmonton.

Back Forty 40s are only one of Back Forty’s numerous product launches this summer, including new dried flower strains and the brand’s first edibles, S’mores flavoured chocolates and Sour Cherry and Sour Grape soft chews. These new products will join Back Forty’s already-popular lineup of vapes and flower, with more detail to follow in coming weeks.

About Back Forty
           
Back Forty is a cannabis brand wholly owned by Auxly Cannabis Group Inc. Through simple, uncomplicated cannabis products, Back Forty invites Canadian cannabis consumers to embrace the freedom of the outdoors. Learn more at b40cannabis.com and stay up-to-date at Twitter: @back40cannabis; Instagram: @backfortycannabis; Facebook: @back40cannabis.

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly is a team of cannabis enthusiasts, entrepreneurs, CPG professionals, scientists and researchers united in a commitment to our consumers. Auxly creates trusted brands and products in an expanding global market through a tailored cultivation platform, purpose-built facilities and state-of-the-art technologies.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

For more information please contact:

Scott Campbell, 647-402-4957, press@35.183.62.152

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: Auxly’s execution of its product development and commercialization strategy; the successful production and launch of future Back Forty products; consumer preferences, political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for Back Forty products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

[i] Back Forty vapes were the top-selling brand in Canada at the end of Q2, 2021, with 13% market share, according to Headset Canadian Insights, Total Canadian Cannabis Sales, June 30, 2021.

[ii] Headset Canadian Insights, Total Canadian Cannabis Sales, June 30, 2021.

TORONTO — Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three and six months ended June 30, 2021. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.

Q2 2021 Highlights and Subsequent Events

• — Total net revenues from sale of adult use cannabis in Canada of $20.9 million for the three months ended June 30, 2021, more than doubling the same period in 2020 and Q1 2021
• — Adjusted EBITDA improves to negative $3.3 million, an improvement of $7.2 million as compared to Q2 2020 and $3.4 million more than the previous quarter
• Continuing improvements in total market share to 4.9% in Q2 2021 (rising to 5.4% in July 2021) while maintaining the #1 LP position in Cannabis 2.0 product sales nationally, with approximately 15.4% market share
• — Further strengthened the Company’s balance sheet with financing transactions and the sale of non-core assets

Read full release on GlobeNewswire here.

Auxly Financials and Filings.

TORONTO — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its second quarter 2021 ended June 30, 2021, on Monday August 16, 2021, before the financial markets open.

The Company will host a conference call to discuss the results. The teleconference details are listed below:

Date: Monday August 16, 2021

Time: 10:00 a.m. EST

North American Toll Free: 1-888-664-6383

A replay of the teleconference will be available within 24 hours after the conclusion of the call on the Company’s website.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

TORONTO, July 12, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is excited to present its product line-up for a summer season filled with brand-new offerings and inspired flavours across multiple categories, including dried flower, vapes, edibles, oil, capsules and concentrates.

Today’s announcement comes as the Company is experiencing success with its previously announced strategic expansion into the dried flower market, including the introduction of dried flower offerings under its Back Forty brand. Auxly’s Back Forty Pine Kush launched in March and it has quickly become one of the most popular flower brands in Canadaⁱ. The success of the Back Forty flower launch has helped Auxly capture approximately 2% of the entire national cannabis flower market (dried flower and pre-rollsⁱⁱ) for the month of June. The Company is delighted with its early success in a segment (dried flower) that accounts for nearly 75% of all Canadian cannabis sales to-date this quarter, or more than $2 billion in sales annuallyⁱⁱⁱ.

With its leadership position in cannabis 2.0 products and the added success of dried flower sales, Auxly has achieved a 5.2% share of the national market for the month of June, as confirmed by Headset Canadian Insights. Further, the Company has moved up to the #6 position among Canadian Licensed Producers for the month of June^iv.

Now, Auxly looks ahead to a summer 2021 lineup designed to delight Canadian cannabis consumers and capture even more of the dried flower market, including exciting new cultivars under the Back Forty brand and the launch of Back Forty pre-rolls.

“Through a focused strategy built on deep consumer insights and executional excellence, we are proud to continue to grow our market share and make a successful entry into the dried flower segment,” said Hugo Alves, CEO of Auxly. “We are excited to continue introducing new products that are responsive to our consumers’ needs, including a more robust line-up of dried flower and pre-roll offerings under our Back Forty and Kolab brands.”

“Canadians deserve something special after a year and a half of pandemic life, and we wanted to make sure our brands rose to the occasion,” said Andrew MacMillan, Senior Vice President, Commercial, Auxly. “Our team of product developers and marketing experts have leveraged consumer insights this summer to bring a suite of high-quality and unique cannabis products that we believe will continue to drive sales and gain meaningful market share for Auxly.”

Here’s a look at the new products Canadian cannabis consumers can look forward to this summer from Auxly’s in-house brands Kolab Project, Back Forty, Foray and Dosecann. More information about these product launches will be announced over the coming weeks. The following products will be available across Canada:

Flower & Pre-rolls:

• Back Forty Animal Mints and Wedding Pie flower. Organically grown, Animal Mints and Wedding Pie are exceptional strains with high THC potencies. These new cultivars will land in the Back Forty where consumers find a better experience for less.
• Back Forty 40s pre-rolls. 40s are machine-rolled straight joints manufactured with state-of-the-art pre-roll technology for a consistent, quality pre-roll that burns evenly with enhanced airflow and flavour. Back Forty 40s will launch with Back Forty’s new organically grown strains Animal Mints and Wedding Pie.
• Kolab Project x Robinsons Growers Series Purple Kush. This summer crossover sees Robinsons’ heavy hitting Purple Kush joining the popular Kolab Project Growers Series, providing cannabis enthusiasts with Robinsons’ superior quality cannabis uplifted by the Kolab Project Growers Series platform.

Edibles:

• Kolab Project 132 Series Live Resin Black Cherry Punch soft chew. A broad-spectrum experience, Canada’s first live-resin soft chew includes aromatic Black Cherry Punch live resin with cherry and floral undertones.
• Back Forty S’mores chocolate. Back Forty’s first edible captures the iconic Canadian campfire treat by combining the flavours of marshmallow, graham crackers and, of course, chocolate.

Kolab Project 232 Series maximizes the flavour and natural expression of the plant for a true-to-strain experience across multiple categories. This summer, Kolab Project puts Slurricane in the spotlight in the following categories:

• Vapes: 1g Live Terpene 510 vape cartridge. Slurricane joins Ice Cream Cake and Black Cherry Punch – both newly launched in the Ontario market.
• Concentrates: Fans of Kolab Project’s best-selling THCA Diamonds will be excited to learn that the brand is issuing a new installment with the Slurricane strain.     

Oils & Capsules:

• Dosecann expands its offerings featuring Auxly’s exclusive, proprietary Ahiflower® Seed Oil and CBD this summer. CBD Omega Lemon Lavender oil and CBD 50 Omega capsules combine high-potency, broad-spectrum cannabinoids with Ahiflower for a sustainably sourced, plant-based, non-GMO source of essential Omega 3 and 6.         

In addition to the above national product launches, Auxly is making the following unique edible products available to select provinces. More information about the distribution of these products will be announced in coming weeks:

• Back Forty Sour Grape and Sour Cherry soft chews. These vegan soft chews join S’mores as the inaugural edibles for Back Forty, in flavours that recall simpler times.
• Foray Strawberry Milkshake White Chocolate. Nothing says summer like a strawberry milkshake. Perhaps Foray’s tastiest edible yet, Strawberry Milkshake White Chocolate is a fresh take on an old-fashioned favourite, perfectly blended to create and rich and creamy mouthfeel, bursting with delicious berry flavour and notes of white chocolate.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

In the country’s largest market, Ontario, Back Forty Pine Kush in 28g units was the #5 dried-flower SKU in the quarter ending June 30, 2021 (source: OCS sales data, as of July 1, 2021); in British Columbia, Back Forty dried flower was the sixth best-seller for Q2, 2021, capturing approximately 3% of the retail market (source: Headset Canadian Insights, British Columbia dried-flower sales, by brand, as of July 1, 2021).
Headset Canadian Insights, Total Canadian Cannabis dried-flower and pre-roll sales, as of July 1, 2021
Source: https://www.bnnbloomberg.ca/cannabis-canada-weekly-canadians-bought-2b-of-dried-flower-last-year-1.1591442

Headset Canadian Insights, Total Canadian Cannabis sales, as of July 1, 2021

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

For more information please contact:
Scott Campbell, 647-402-4957, press@35.183.62.152

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes but is not limited to: the successful production and launch of current and future Company products; the Company’s execution of its product development, commercialization strategy, and expansion plans; the ability of the Company to maintain and grow its market share; the relevance of the Company’s proposed products; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party sources, the accuracy of which has not been verified by Auxly. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, Auxly does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, July 6, 2021 – Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) a leading consumer packaged goods company in the cannabis products market, is pleased to announce the implementation of amendments to certain provisions of its previously issued $123 million debenture (the “Debenture”) and investor rights agreement (the “Investor Rights Agreement”) dated September 25, 2019 (collectively, the “Amendments”) with its strategic partner, Imperial Brands PLC (“Imperial Brands”), pursuant to the terms of the previously announced amending agreement dated April 19, 2021.

Pursuant to the Amendments, Imperial and Auxly have: (i) extended the maturity date of the Debenture by 24 months from September 25, 2022 to September 25, 2024; (ii) provided Imperial with the right, on an annual basis, to convert any or all of the accrued and unpaid interest on the Debenture then outstanding into Common Shares (the “Interest Conversion Election”), at a conversion price equal to the five-day volume weighted average trading price of the Common Shares on the date that Interest Conversion Election is made; (iii) provided that the payment of interest under the Debenture, which currently accrues at a rate of 4% per annum and is payable annually, will remain unchanged but will be payable on maturity of the Debenture; and (iv) re-instated certain approval rights of Imperial under the Investor Rights Agreement.

The Amendments were subject to, among other things, the Company obtaining minority shareholder approval in accordance with Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions, which was obtained at the Company’s annual and special meeting of shareholders held on June 28, 2021.

The Company is also pleased to announce that it has completed the sale of its interest in 2368523 Ontario Limited (d/b/a Curative Cannabis) to a private purchaser for total proceeds to the Company of $6 million.   The Company acquired substantially all the shares and assets of Curative Cannabis pursuant to a foreclosure order issued on November 27, 2019, which assets included a cannabis cultivation facility located in Chatham-Kent, Ontario. The facility has remained non-operational since the foreclosure and while exploring all possible options with respect to the use, commercialization and/or sale of the asset the Company determined such asset was not essential to the Company’s operations and strategy. The disposition of this non-core asset allows the Company to strengthen its financial position with non-dilutive capital that it can deploy into its core business.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Auxly’s head office is located at 777 Richmond St. W, Unit 002, Toronto, ON M6J 0C2. Imperial Brand’s head office is located at 121 Winterstoke Road, Bristol, UK BS3 2LL.

Early Warning Disclosure

An affiliate of Imperial Brands holds the Debenture and assuming the Debenture is exercised in full as of the date hereof (but excluding any exercise of the Interest Conversion Election by the holder of the Debenture), Imperial Brands and its affiliates would have beneficial ownership of 157,983,592 Common Shares or approximately 16% of the issued and outstanding Common Shares (calculated on a non-diluted basis).

Imperial Brands intends to review its investment in the Company on a continuing basis and may, subject to the terms of the Investor Rights Agreement, purchase or sell common shares, either on the open market or in private transactions, or exercise the Debenture in the future, in each case, depending on a number of factors, including general market and economic conditions and other factors and conditions Imperial Brands deems appropriate.

An amended early warning report will be filed by Imperial Brands with applicable Canadian securities regulatory authorities. To obtain a copy of the early warning report, please contact Daniel Glavin at 416- 869-5500.

Notice Regarding Forward Looking Information:  

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the Company’s execution of its product development, commercialization strategy and expansion plans; consumer preferences; political change; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information included in this release including, but not limited to, whether: general economic, financial market, legislative, regulatory, competitive and political conditions in which Auxly operates will remain the same. Additional risk factors are disclosed in the annual information form of Auxly for the financial year ended December 31, 2020 dated April 23, 2021.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this news release is based on information currently available and what management believes are reasonable assumptions. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this news release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, June 29, 2021 — Auxly Cannabis Group Inc. (TSX- XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) announced today the voting results from its annual general and special meeting of shareholders held on June 28, 2021 (the “Meeting”).

A total of 132,758,409 common shares of the Company, representing 17.62% of the issued and outstanding common shares of the Company, were voted in connection with the Meeting by shareholders and proxy holders.

All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s information circular dated May 20, 2021 (the “Circular”), were approved by the requisite majority of the votes cast at the Meeting. The results are set out below.

Each of the directors listed as a nominee in the Circular was elected as a director of the Company at the Meeting. The detailed results can viewed here at GlobeNewswire.

TORONTO, ON – June 14, 2021 – Auxly Cannabis Group Inc. (“Auxly” or the “Company”) (TSX: XLY) (OTCQX: CBWTF) is pleased to announce the closing of its bought deal short form prospectus offering pursuant to which the Company issued 54,763,000 units of the Company (the “Units“) at a price of $0.315 per Unit for gross proceeds to the Company of $17,250,345 (the “Offering“), including the full exercise of the over-allotment option.

The Offering was led by ATB Capital Markets Inc. as sole bookrunner and Cantor Fitzgerald Canada Corporation acting as co-lead underwriters, together with a syndicate of underwriters including Desjardins Capital Markets, Raymond James Ltd., and Mackie Research Capital Corporation (collectively, the “Underwriters”).  A.G.P./Alliance Global Partners was acting as the sole U.S. sub-agent and financial advisor to the Company in connection with the Offering in the United States.

Each Unit is comprised of one common share of the Company (each a “Common Share“) and one-half of oneCommon Share purchase warrant of the Company (each whole warrant, a “Warrant“). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.38 at any time up to 36 months from closing of the Offering.

The net proceeds from the Offering will be used to continue to pursue strategic growth initiatives, including continued development, commercialization and expansion of its product portfolio, and for general corporate purposes.

The Units were offered by way of a prospectus supplement (the “Prospectus Supplement“) to the Company’s short form base shelf prospectus dated March 18, 2021 (the “Base Shelf Prospectus“), which has been filed in those provinces of Canada as the Company and the Underwriters may designate (excluding Quebec) pursuant to National Instrument 44-101 – Short Form Prospectus Distributions and National Instrument 44-102 – Shelf Distributions. The Units were also offered in the United States on a private placement basis pursuant to an appropriate exemption from the registration requirements under applicable U.S. law.

The Prospectus Supplement and the Base Shelf Prospectus contain important detailed ‎information about the Offering. Copies of the Prospectus Supplement and the Base Shelf ‎Prospectus are available on the Company’s profile on SEDAR at www.sedar.com. ‎Copies of the Prospectus Supplement and the Base Shelf Prospectus may also be obtained in ‎Canada from ATB Capital Markets Inc. at Suite 410, 585 8 Avenue SW Calgary, AB T2P 1G1 or by email at prospectus@atb.com.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

ON BEHALF OF THE BOARD 

“Hugo Alves“ CEO 

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team:

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. In particular, this news release contains forward-looking statements pertaining to expected use of proceeds for the Offering.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information included in this release including, but not limited to: general economic, financial market, legislative, regulatory, competitive and political conditions in which Auxly operates will remain the same. Additional risk factors are disclosed in the annual information form of Auxly for the financial year ended December 31, 2020 dated April 23, 2021.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this news release is based on information currently available and what management believes are reasonable assumptions. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this news release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, ON – June 9, 2021 – Auxly Cannabis Group Inc. (“Auxly” or the “Company”) (TSX: XLY) (OTCQX: CBWTF) is pleased to announce that it has entered into an agreement pursuant to which ATB Capital Markets Inc. (“ATB”), as sole bookrunner, and Cantor Fitzgerald Canada Corporation, acting as co-lead underwriters of the Offering, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase 47,620,000 Units of the Company (the “Units”), on a bought-deal basis at a price per Unit of $0.315 (the “Issue Price”) for gross proceeds of $15,000,300 (the “Offering“). A.G.P./Alliance Global Partners is acting as the sole U.S. sub-agent and financial advisor to the Company in connection with the Offering in the United States.

Each Unit shall be comprised of one common share of the Company (each a “Common Share“) and one-half of oneCommon Share purchase warrant of the Company (each whole warrant, a “Warrant“). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.38 at any time up to 36 months from closing of the Offering.

The Company has granted the Underwriters an option (the “Underwriters’ Option”) to increase the size of the Offering by up to an aggregate number of Units equal to 15% of the total number of Units issued under the Offering, such Underwriters’ Option being exercisable at any time and from time to time up to 30 days following the closing of the Offering.

The Company intends to use the net proceeds to continue to pursue strategic growth initiatives, including continued development, commercialization and expansion of its product portfolio, and for general corporate purposes.

The closing of the Offering is expected to occur on or about the week of June 14, 2021 (the “Closing”), or such later or earlier date as the Underwriters and the Company may agree upon,and is subject to the Company receiving all necessary regulatory approvals, including the approval of the necessary securities regulatory authorities.

The Units will be offered by way of a prospectus supplement (the “Prospectus Supplement“) to the Company’s short form base shelf prospectus dated March 18, 2021 (the “Base Shelf Prospectus“), which will be filed in those provinces of Canada as the Company and the Underwriters may designate (excluding Quebec) pursuant to National Instrument 44-101 – Short Form Prospectus Distributions and National Instrument 44-102 – Shelf Distributions. The Units may also be offered in the United States on a private placement basis pursuant to an appropriate exemption from the registration requirements under applicable U.S. law.

The Prospectus Supplement and the Base Shelf Prospectus will contain important detailed ‎information about the Offering. Copies of the Prospectus Supplement, following the filing thereof, and the Base Shelf ‎Prospectus will be available on the Company’s profile on SEDAR at www.sedar.com. ‎Copies of the Prospectus Supplement and the Base Shelf Prospectus may also be obtained in ‎Canada from ATB Capital Markets Inc. at Suite 410, 585 8 Avenue SW Calgary, AB T2P 1G1 or by email at prospectus@atb.com.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

ON BEHALF OF THE BOARD 

“Hugo Alves“ CEO 

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team:

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the receipt of the necessary regulatory approvals for the Offering; the timing and proposed completion of the Offering; the expected use of proceeds of the Offering by the Company;  the pricing of the Offering;, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information included in this release including, but not limited to: whether the Company can complete the Offering on the anticipated terms and timeline; whether the Company can obtain regulatory approval of the Offering on the proposed terms and timeline; and general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2020 dated April 23, 2021.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this news release is based on information currently available and what management believes are reasonable assumptions. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this news release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, May 31, 2021 – Auxly Cannabis Group Inc. (TSX- XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) announced today that it will hold its Annual General and Special Meeting of Shareholders (the “Meeting”) on Monday, June 28, 2021 at 2:00 p.m. EST at the offices of Bennett Jones LLP, 3400 One First Canadian Place, Toronto, Ontario, M5X 1A4. 

COVID-19 Guidance

The Company is strongly discouraging physical attendance at the meeting to proactively deal with potential issues arising from the unprecedented public health impact of COVID-19 and to limit and mitigate risks to the health and safety of its communities, shareholders, employees, directors and other stakeholders. The Meeting will not be open to the general public and will be restricted to registered shareholders (who are also strongly discouraged from attending) and duly appointed proxyholders only. To ensure compliance with public health guidance on public gatherings, registered shareholders who wish to attend the Meeting are required to provide the Company with at least 48 hours advance notice, and any shareholder who does not provide such notice and receive approval from the Company to attend will not be admitted to the Meeting. Notice can be provided at IR@35.183.62.152.

To allow shareholders to follow the conduct of the Meeting, the Company is providing an audio teleconference that can be used by participants to listen to the Meeting in real time.

Teleconference Details

Date: Monday June 28, 2021

Time: 2:00 p.m. EST

North American Toll Free: 1-888-664-6383

Conference ID: 94023704

Please note that shareholders will not be entitled to vote at, or otherwise participate in, the Meeting by way of teleconference or other electronic means, and so this year, more than ever, we strongly encourage shareholders to vote in advance of the Meeting in accordance with the instructions provided in the materials for the Meeting, including the Management Information Circular, which has been mailed to shareholders and is available on SEDAR as well as the Company’s website.  

There will be no formal question and answer period following the Meeting and presentation by management, however, shareholders are welcome to submit questions in advance to the Investor Relations inbox at IR@35.183.62.152, and the Company will respond to select questions submitted before June 21, 2021 on the call.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, May 28, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three months ended March 31, 2021. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com.

Q1 2021 Highlights and Subsequent Events

• — Recorded net revenues of $10M for the three months ended March 31, 2021, an increase of 1% from the same period in 2020.
• — Maintained leadership position in Cannabis 2.0 product sales with approximately 12.6% national market share¹ in the quarter.
• — SG&A declined another 5% from the previous quarter.
• — Continued to launch new innovative products to the Canadian market with the introduction of the Company’s first cannabis concentrate, 232 Series Diamonds under its Kolab Project brand and an industry-leading, high-potency topical, Dosecann Daily Relief CBD cream.
• — Welcomed Andrea Fraser to the Auxly Family as Chief People Officer.
• — Further strengthened the Company’s balance sheet with a $8M private placement offering of units.

Read full release on GlobeNewswire here.

Auxly Financials and Filings.

TORONTO, May 27, 2021 — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, announced today that it has entered into a definitive agreement with Myconic Capital Corp. (NEO: MEDI) (“Myconic”), an investment issuer with a diversified portfolio focused on emerging companies, pursuant to which Myconic will acquire all of the issued and outstanding shares of KGK Science Inc. (“KGK”) (the “Transaction”) for up to $16.5 million in value comprised of:

• $12.5 million purchase price from Myconic in the form of:
  • $1.5 million in cash payable on the closing date of the Transaction;
  • $1.0 million in cash payable six months after the closing date of the Transaction; and
  • $10.0 million in common shares in the capital of Myconic (“Myconic Shares”) at a price per Myconic Share of $1.55 (being 6,451,612 Myconic Shares) all to be issued on the closing date of the Transaction, with equal tranches becoming freely tradeable on the four, six, nine and 12 month anniversaries of the closing date of the Transaction;

• $1.5 million milestone payment, payable in cash or Myconic Shares, at the option of Myconic, if KGK achieves gross revenues of $8 million in any 12-month period during the two years following the closing date of the Transaction; and
• $2.5 million credit against future KGK services, reflected in a 10-year service agreement between Auxly and KGK.

The Transaction is expected to close on or around the week of June 7, 2021 and is subject to customary closing conditions and regulatory approvals, including the approval of the NEO Exchange.

“This agreement with Myconic is a win-win for Auxly and its shareholders in both the short and long-term, as the additional capital can be deployed into our core business and accelerates Auxly’s path to profitability, while continuing our long-standing relationship with KGK to leverage their deep clinical expertise as we continue to bring innovative cannabis products to market that meet our consumer promise of quality, safety and efficacy,” said Hugo Alves, CEO, Auxly. “KGK is an outstanding CRO that knows how to unlock value in emerging industries through clinical work and will be an excellent fit with the team at Myconic.”

“This is an exciting day for KGK as we look to bring our years of experience as a leading CRO into the field of psychedelics research, which holds great promise for helping people overcome a wide range of illnesses,” said Najla Guthrie, President & CEO, KGK. “We’ve gained invaluable insight from our partnership with Auxly and look forward to continuing our relationship and helping them bring safe and effective cannabis products to market.”

“The investment that Myconic is making to acquire KGK is very exciting and I look forward to welcoming the KGK team and their valuable expertise to our company,” said Robert Meister, Chief Executive Officer of Myconic. “On behalf of the Board of Directors, I would like to commend Auxly on their professionalism and transparency throughout the Transaction thus far and look forward to our companies working together for many years into the future, long after the closing date,” added Mr. Meister.

With the sale of KGK, Auxly gains additional liquidity to support the Company’s ongoing commercial operations as it continues to expand its product offering in Canada and execute on its business strategy.

ON BEHALF OF THE BOARD
“Hugo Alves” CEO

About Myconic Capital Corp. (CSE: MEDI)

Myconic Capital Corp is an investment issuer with a diversified portfolio that is focused on emerging companies active in the high-tech, real estate, cannabis, mining and health and wellness sectors.

About Auxly Cannabis Group Inc. (TSX: XLY)

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the receipt of the necessary regulatory approval for the Transaction and the timing of such approval; the timing and proposed completion of the Transaction; the Company’s execution of its product development and commercialization strategy; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Transaction can be completed on the anticipated terms and timeline; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2020 dated April 23, 2021.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release. 

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, Auxly does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. 

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, May 20, 2021 — Auxly Cannabis Group Inc. (“Auxly” or the “Company”) (TSX: XLY) (OTCQX: CBWTF) is pleased to announce that it has closed its previously announced private placement offering of units (the “Units“) to an institutional investor (the “Investor”) for gross proceeds of approximately $8.0 million (the “Offering”). Pursuant to the Offering, the Company issued 23,880,598 Units of the Company at a price of $0.335 per Unit. ATB Capital Markets Inc. acted as exclusive agent on the Offering.

Each Unit is comprised of one common share of the Company (each a “Common Share“) and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant“). Each Warrant entitles the Investor to purchase one Common Share at an exercise price of $0.42 at any time up to 36 months from closing of the Offering.

The net proceeds from the Offering will be used for working capital and general corporate purposes.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

ON BEHALF OF THE BOARD 

“Hugo Alves“ CEO 

About Auxly Cannabis Group Inc. (TSX: XLY)

Auxly is a vertically integrated cannabis company dedicated to bringing branded cannabis products to market that consumers love and trust. Our team of professionals and cannabis enthusiasts are united by a shared commitment to quality and our consumers. We build powerful value propositions with brands that connect and products that deliver on our consumer promise of quality, safety and efficacy.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:
For investor enquiries please contact our Investor Relations Team:
Email: IR@35.183.62.152 
Phone: 1.833.695.2414

Media Enquiries (only): 
For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152  

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the expected use of proceeds of the Offering; future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, May 13, 2021 — Auxly Cannabis Group Inc. (“Auxly” or the “Company”) (TSX: XLY) (OTCQX: CBWTF) is pleased to announce that it has entered into an agreement with an institutional investor (the “Investor”) pursuant to which the Investor has agreed to purchase, on a private placement basis, 23,880,597 units (the “Units“) of the Company at a price of $0.335 per Unit for aggregate gross proceeds of approximately $8.0 million (the “Offering“). ATB Capital Markets Inc. is acting as exclusive agent on the Offering.

Each Unit shall be comprised of one common share of the Company (each a “Common Share“) and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant“). Each Warrant shall entitle the Investor to purchase one Common Share at an exercise price of $0.42 at any time up to 36 months from Closing (as defined below).

The net proceeds from the Offering will be used for working capital and general corporate purposes.

The closing of the Offering is expected to occur during the week of May 17, 2021 (the “Closing”), or such later or earlier date as the Investor and the Company may agree upon, and is subject to the completion of formal documentation and the Company receiving all necessary regulatory approvals, including the approval of the Toronto Stock Exchange. The Units will be offered pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws and shall be subject to a customary four-month hold period under Canadian securities laws.

No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.   This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

ON BEHALF OF THE BOARD 

“Hugo Alves“ CEO 

About Auxly Cannabis Group Inc. (TSX: XLY)
Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry-first movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:
For investor enquiries please contact our Investor Relations Team:
Email: IR@35.183.62.152
Phone: 1.833.695.2414

Media Enquiries (only): 
For media enquiries or to set up an interview please contact:
Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the proposed completion of, and the expected use of proceeds of, the Offering; the Company’s response to the COVID-19 pandemic; future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.
Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2020 dated April 23, 2021.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward‐looking information.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

 TORONTO, Ontario, May 5, 2021 – Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that it has hired Andrea Fraser as Chief People Officer. In this new role, Ms. Fraser will lead all aspects of the Company’s human resources, including crafting talent acquisition strategies, promoting inclusion in the workplace and further developing and evaluating career paths to meet the Company’s business goals. Ms. Fraser will also manage Auxly’s ongoing response to the impacts of COVID-19 as it relates to its employees and office spaces. 

Ms. Fraser brings extensive experience and deep knowledge of leading People and Culture strategy and initiatives for multinational CPG and digital marketing companies, most recently working as Director, Global Human Resources at Tilray. 

“We are delighted to welcome Andrea to the Auxly Family,” said Hugo Alves, CEO of Auxly. “We believe she is the right leader to help us continue building an engaged, inclusive and high-performing culture at Auxly.” 

Ms. Fraser commented, “I couldn’t be more excited to be joining Auxly as its new Chief People Officer. The highly engaged culture that Auxly has created is truly special and I look forward to helping them take these strengths to a new level of performance and success.” 

ON BEHALF OF THE BOARD 

“Hugo Alves” CEO 

About Auxly Cannabis Group Inc. (TSX: XLY) 

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market. 

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations: 

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152 

Phone: 1.833.695.2414 

Media Enquiries (only): 

For media enquiries or to set up an interview please contact: 

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information: 

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the Company’s response to the COVID-19 pandemic; future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally. 

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. 

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Ms. Fraser brings extensive experience and deep knowledge of leading People and Culture strategy and initiatives for multinational CPG and digital marketing companies, most recently working as Director, Global Human Resources at Tilray. 

“We are delighted to welcome Andrea to the Auxly Family,” said Hugo Alves, CEO of Auxly. “We believe she is the right leader to help us continue building an engaged, inclusive and high-performing culture at Auxly.” 

Ms. Fraser commented, “I couldn’t be more excited to be joining Auxly as its new Chief People Officer. The highly engaged culture that Auxly has created is truly special and I look forward to helping them take these strengths to a new level of performance and success.” 

ON BEHALF OF THE BOARD 

“Hugo Alves” CEO 

About Auxly Cannabis Group Inc. (TSX: XLY) 

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market. 

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/. 2 

Investor Relations: 

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152 

Phone: 1.833.695.2414 

Media Enquiries (only): 

For media enquiries or to set up an interview please contact: 

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information: 

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the Company’s response to the COVID-19 pandemic; future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally. 

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. 

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release. 

View on GlobeNewswire here.

TORONTO, Ontario, May 3, 2021 – Today Dosecann, an in-house brand owned by Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly”), announces the launch of Dosecann Daily Relief CBD Cream, a new, high-strength, differentiated cannabis topical cream for Canadian wellness consumers. With 1,200mg of cannabidiol (CBD) per 60 ml unit, Dosecann Daily Relief CBD Cream has double the potency of any CBD topical currently available in the Canadian marketplace and is competitively priced to deliver the best value for a CBD topical[i]. Dosecann Daily Relief CBD Cream is available to order now for wholesalers across Canada, is available to consumers now in British Columbia and Saskatchewan and will also be available in Alberta in coming weeks.  

Dosecann Daily CBD Cream was developed by a team of scientists, researchers and formulation experts at Auxly’s state-of-the-art laboratory in Charlottetown, PEI, under the direction of Dr. Bob Chapman, Chief Science Officer, Dosecann.

“Topicals were among the very first products we conceived of at Dosecann and I’m extremely proud that after thorough development and testing, we’ve landed on a formula that we believe is the best in the marketplace,” said Dr. Chapman. “Consumers use topicals to provide daily relief from a wide variety of symptoms such as localized pain relief, muscle soreness, tension and inflammation. Our team was driven to ensure that Dosecann Daily Relief CBD Cream offers industry-leading potency along with a formulation designed to boost CBD penetration and provide the skin moisturizing properties of high-end skin creams.”

“We’re excited to launch Dosecann Daily Relief CBD Cream and expand our expertise in the 2.0 segment into topicals,” said Brad Canario, Brand Director, Auxly. “We know from research that topicals are a high-frequency segment, with nearly 50% of topical consumers using daily, and further, that amongst Canadian cannabis users, creams are the #1 topicals format. We believe we have a truly differentiated product for wellness consumers looking for daily relief from a variety of symptoms and, as always, we focused on our pillars of quality, safety and efficacy at every stage of product development.”

The proprietary Dosecann Daily Relief CBD Cream formula combines high-quality CBD extract with Natralipid™ Meadowfoam seed oil, a plant-based emollient found in high-end skin creams and valued for moisturization, transdermal barrier repair, skin penetration and unsurpassed stability. The result is a product that promotes the fast, effective absorption of high-quality CBD extract so that the cannabinoids can get where they’re needed quickly, all the while soothing the skin by locking-in moisture without leaving a greasy feeling behind. Dosecann Daily Relief CBD Cream has a mild, neutral bamboo scent and is packaged in a recyclable glass jar with a built-in seal to preserve freshness. 

Dosecann Daily Relief CBD Cream is the latest cannabis 2.0 release from Auxly, who achieved the #1 market-share position for Cannabis 2.0 products in 2020. With today’s launch, Dosecann expands its offering of natural, science-backed products, which includes oils and precision-dosed capsules made with omega-rich Ahiflower™ oil.

About Dosecann          
Dosecann is a world-class developer of innovative cannabis products for the wellness-focused consumer, wholly owned by Auxly Cannabis Group Inc.  Proudly processed at Auxly’s 52,000 sq. ft., state-of-the-art facility in Charlottetown, Prince Edward Island, Dosecann products are developed and manufactured on-site by a world-class team of scientists and experts, ensuring high-quality, precision and consistency. Dosecann’s wellness products, available at licensed cannabis retailers across Canada, consist of non-GMO capsules and oils. Built on the pillars of quality, safety and efficacy, Dosecann is cannabis – down to a science.

Learn more at dosecann.com and stay up to date at Twitter: @Dosecann; Instagram: @dosecann; Facebook: @dosecann.

About Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF)  
Auxly is leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

For more information please contact:
Scott Campbell, 647-402-4957, press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes but is not limited to: Dosecann’s execution of its product development and commercialization strategy; consumer preferences; political change, future legislative and regulatory developments involving cannabis, cannabis products and cannabis health products; and competition and other risks affecting Auxly in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for current and future Dosecann products by consumers and provincial purchasers, and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party sources, the accuracy of which has not been verified by Auxly. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, Auxly does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock  Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, April 26, 2021 – Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a consumer packaged goods company in the cannabis products market, today released its fourth quarter and full year 2020 financial results. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.

2020 Highlights

• – Recorded net revenues of $50.8 million in 2020, including $46.6 million in cannabis net revenues, an increase of 508% compared to 2019. 
• – Fourth quarter net Cannabis revenues of $18.3 million.
• – Achieved the #1 LP position in Canada for Cannabis 2.0 product sales^[1] in 2020 with approximately 14% market share in the category. 
• – Expanded into the Cannabis 1.0 market with the launch of Robinsons premium dried flower and
• – Kolab Project Growers Series collaborations with Lotus Cannabis and Safari Flower Co.  
• – Continued efforts to reduce SG&A which were below $10 million in the fourth quarter. 
• – Further strengthened the Company’s balance sheet with financing transactions.

View full news release here.

Read on GlobeNewswire here.

TORONTO, Ontario, April 19, 2021 – Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, is pleased to announce an agreement with its strategic partner, Imperial Brands PLC (“Imperial Brands”) to amend certain provisions of its previously issued $123 million debenture (the “Debenture”) and investor rights agreement (the “Investor Rights Agreement”) dated September 25, 2019 (collectively, the “Amendments”). 

Pursuant to the Amendments, Imperial and Auxly have agreed to extend the maturity date of the Debenture by 24 months from September 25, 2022 to September 25, 2024.

The Amendments will also provide Imperial with the right, on an annual basis, to convert any or all of the accrued and unpaid interest on the Debenture then outstanding into Common Shares (the “Interest Conversion Election”), at a conversion price equal to the five-day volume weighted average trading price of the Common Shares on the date that Interest Conversion Election is made.  Auxly and Imperial have also agreed that the interest rate under the Debenture, which currently accrues at a rate of 4% per annum and is payable annually, will remain unchanged but will be payable on maturity of the Debenture.

Lastly, the Amendments provide for the re-instatement of certain approval rights of Imperial under the Investor Rights Agreement.

As a result of the Amendments, the Company will see a significant improvement to the near-term cash requirements of the business, enabling it to focus on executing on its business strategies that will position it for long-term growth to the benefit of its stakeholders.

“After the great progress we’ve made over our first year of commercial operations, including achieving the #1 position in the 2.0 market and breaking into the top 10 licensed producers by overall market share, this agreement to extend the debt maturity date for 24 months demonstrates the confidence Imperial Brands has in our strong growth and differentiated strategy,” said Hugo Alves, CEO of Auxly.  “The extension and deferral of interest will improve our cash position, strengthen our balance sheet and remove potential overhang on the Company’s share price.  I would like to thank our partners at Imperial Brands for their ongoing commitment to our Company and look forward to our continued relationship.”

Auxly remains Imperial Brands’ exclusive global partner for any future development, manufacture, commercialization, sale and distribution of cannabis products.

The Debentures are convertible into Common Shares at a price of $0.81 per share at any time prior to the close of business on the business day immediately preceding maturity. 

The implementation of the Amendments is subject to the satisfaction of a number of conditions, including, among other things, the approval of the TSX Venture Exchange, and minority shareholder approval of the Amendments in accordance with Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”), as more particularly described below.

Related Party Transaction

Imperial is considered a “related party” of the Company, and the Amendments constitute a “related party transaction”, as such terms are defined by MI 61-101. The Company is relying on an exemption from the formal valuation requirements of MI 61-101 available on the basis of the securities of the Company not being listed on specified markets prescribed by MI 61-101.

Pursuant to MI 61-101, the Amendments are subject to the approval by shareholders of the Company holding more than 50% Common Shares represented in person or by proxy at a duly constituted meeting of the shareholders of the Company, excluding the votes attaching to the Common Shares held by Imperial and its associates and affiliates (the “Minority Shareholder Approval”). The Company intends to obtain the Minority Shareholder Approval at its upcoming annual and special meeting of shareholders (the “Company Meeting”). Further particulars of the Amendments will be specified in the management information circular that will be sent to shareholders in advance of the Company Meeting.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX.V: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: obtaining the necessary regulatory approval and Minority Shareholder Approval for the Amendments and the timing of such approvals; the anticipated benefits of the Amendments; the Company’s execution of its product development and commercialization strategy; consumer preferences, political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company is able to obtain regulatory approval and Minority Shareholder Approval for the Amendments on the proposed terms and timeline; the expected benefits of the Amendments materialize in the manner expected, or at all; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, legislative, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2019 dated May 13, 2020.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

TORONTO, Ontario, April 16, 2021 – Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that it has received final approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares on the TSX.

Auxly’s common shares will commence trading on the TSX at market open on Tuesday, April 20, 2021 under its existing symbol “XLY”. In connection with listing on the TSX, the last day of trading on the TSXV will be April 19, 2021 and the Company’s shares will be delisted from the TSXV upon commencement of trading on the TSX. The Company’s shares will continue to trade on the OTCQX market under the symbol “CBWTF.”  Shareholders will not be required to take any action in connection with the graduation and listing on the TSX.

ON BEHALF OF THE BOARD

“Hugo Alves” CEO

About Auxly Cannabis Group Inc. (TSX.V: XLY)

Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.

Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.

Investor Relations:

For investor enquiries please contact our Investor Relations Team: 

Email: IR@35.183.62.152

Phone: 1.833.695.2414

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:

Email: press@35.183.62.152 

Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the listing of the Company’s common shares on the TSX; future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company operates will remain the same. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View on GlobeNewswire.